COSIMIA
DEAD

Serial Number

88647584

Owner

ROCHE MOLECULAR SYSTEMS, INC.

Attorney

Justin L. Sage

Filing Date

Oct 9, 2019

Add to watchlist:

No watchlists yet
View on USPTO

COSIMIA Trademark

Serial Number: 88647584

COSIMIA is a trademark filed by ROCHE MOLECULAR SYSTEMS, INC. on October 9, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

ROCHE MOLECULAR SYSTEMS, INC. (198 trademarks)

Pleasanton, CA 94588

Entity Type: 03

Trademark Details

Filing Date

October 9, 2019

Registration Date

Not Registered

Published for Opposition

September 8, 2020

Goods & Services

Clinical or medical diagnostic apparatus and instruments, namely, nucleic acid sequencers, imaging devices and analyzers; medical diagnostic apparatus and instruments for the amplification and analysis of nucleic acids and the preparation of nucleic acid libraries sold together in the form of kit; medical equipment, namely, devices for analyzing nucleic acids and for DNA sequencing for the purpose of rendering medical treatment and diagnosis, and downloadable software for use therewith sold as a unit

Scientific equipment, apparatus and instruments, namely, genome sequencer for scientific, pharmaceutical and medical research purposes; scientific instruments for use in scientific research, namely, nucleic acid sequencers, imaging devices and analyzers; laboratory apparatus for sample preparation, amplification, mixing, hybridization, incubation, and washing, namely, arrays, beads, bead sets and flow cells; laboratory equipment, namely, devices for analysis of nucleic acids and for DNA sequencing; automated laboratory apparatus and systems, namely, sample loaders and bar code readers; downloadable software used for genotyping and gene expression microarrays for scientific, pharmaceutical and medical research purposes; downloadable software used in analyzing, managing and visualizing DNA sequencing data; downloadable software used for preparation of nucleic acids libraries; computer hardware and downloadable software for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, for use in the fields of scientific, diagnostic and clinical research and for clinical diagnostic purposes

In vitro diagnostic agents, namely, reagents and control solutions for analysis of biological samples, all for medical diagnostic purposes; reagents for medical diagnostic use; medical diagnostic assays and reagents for testing of biological samples; reagent kits consisting of enzymes, oligonucleotides, nucleic acids, natural and modified nucleotides, buffers, labels, and substrates for medical diagnostic purposes; medical diagnostic test kits comprising reagents for testing body fluids to determine fetal chromosomal abnormalities; chemical reagents, preparations and test kits for fetal nucleic acid analysis for medical use; diagnostic kits consisting primarily of reagents for nucleic acid detection and analysis for medical diagnostic purposes; reagents for medical diagnostic use and diagnostic kits comprised of medical diagnostic reagents and assays for use in connection with DNA sequencing and genetic analysis

In vitro diagnostic agents, namely, chemical control solutions for calibrating and monitoring the accuracy and function of instruments and test results, chemical additives, enzymes, reagents, organisms and proteins for use in science, research and industry; reagents for cell separation for scientific or research purposes; labeling reagents for scientific or research purposes; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, cultivation, analysis and counting of material, in particular of chemicals and biological material, all for scientific or research purposes; reagents featuring magnetic beads for scientific or research purposes; antibody reagents for scientific or research purposes; buffer solutions and reagents for use with laboratory apparatus, namely, separation apparatus and analysis apparatus, for scientific or research purposes; reagents for processing biological material, namely, tissue, bone marrow, cells, blood and components thereof for scientific or research purposes; reagents, enzymes, and nucleotides for nucleic acid sequencing for scientific or research purposes; diagnostic tests comprised of reagents and chemical test kits for determination of genetic information for scientific or research purposes; reagents for scientific or medical research use for analyzing cells, proteins, nucleic acids, sequencing DNA, genotyping, gene expression profiling and high through-put screening; reagent kits composed primarily of oligonucleotides, enzymes and buffers for nucleic acid detection in the fields of scientific, pharmaceutical and medical research; nucleic acids, enzymes, buffers and chemical reagents for use in genotyping and gene expression test kits for detecting and analyzing nucleic acids for scientific or research purposes; assays and reagents for scientific or medical research use; diagnostic tests and test kits primarily composed of reagents and nucleotides for determination of genetic information for scientific or research purposes; reagents and chemical test kits for scientific and research use in connection with DNA sequencing and genetic analysis

Scientific research in the field of genome sequence analysis and reporting; medical research in the field of genome sequence analysis and reporting; DNA screening for scientific research purposes; providing reagent sample testing services for others in the fields of science and scientific research; computer services, namely, cloud hosting provider services for storing, analyzing and sharing biological information; computer services, namely, hosting an interactive web site that allows users to store, analyze and share data in the field of life science; technical support services, namely, infrastructure management services for monitoring, administration and management of cloud computing it and application systems in the field of life science; consulting services in the field of cloud computing in the field of life science; providing online non-downloadable software for the custom design and ordering of assays and reagents; design and development of laboratory apparatus, instruments and computer systems for use in analysis of biomolecules; installation and maintenance of computer software and database systems used in the field of analysis of biomolecules; consultancy, information and advisory services in the field of scientific analysis of biomolecules; product development, namely, developing equipment for use in preparing, detecting, analyzing and sequencing nucleic acids and other biological molecules, and automated laboratory equipment and systems, and computer systems for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data to the order and specification of others, all the foregoing in the fields of scientific and clinical research; clinical diagnostic services in preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules from human beings or animals for scientific and medical research purposes; design and development of medical diagnostic apparatus and instruments and computer systems for use in analysis of biomolecules; scientific consulting and research services and clinical laboratory testing services in the fields of amplification, detection, sequencing and analysis of nucleic acids and the preparation of nucleic acid libraries; nucleic acid sequencing services for scientific research purposes; scientific research, namely, computational analysis of nucleic acid sequences and development of computational technologies for the analysis of nucleic acid sequences and instruments for the amplification and analysis of nucleic acids and the preparation of nucleic acid libraries sold together in the form of kit

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 4, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 4, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 2, 2023 EXRA
SOU EXTENSION 5 GRANTED
May 1, 2023 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 1, 2023 AITU
SOU EXTENSION 5 FILED
Apr 26, 2023 EXT5
SOU TEAS EXTENSION RECEIVED
Apr 26, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 27, 2022 EXRA
SOU EXTENSION 4 GRANTED
Oct 25, 2022 EX4G
SOU EXTENSION 4 FILED
Oct 25, 2022 EXT4
SOU TEAS EXTENSION RECEIVED
Oct 25, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 9, 2022 EXRA
SOU EXTENSION 3 GRANTED
Apr 7, 2022 EX3G
SOU EXTENSION 3 FILED
Apr 7, 2022 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 7, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 28, 2021 EXRA
SOU EXTENSION 2 GRANTED
Oct 26, 2021 EX2G
SOU EXTENSION 2 FILED
Oct 26, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 26, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 20, 2021 EXRA
SOU EXTENSION 1 GRANTED
Apr 16, 2021 EX1G
SOU EXTENSION 1 FILED
Apr 16, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 16, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 3, 2020 NOAM
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 19, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 19, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 19, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 19, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 19, 2020 COAR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 8, 2020 NPUB
PUBLISHED FOR OPPOSITION
Sep 8, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 19, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 30, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 7, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 7, 2020 CRFA
ASSIGNED TO LIE
Jul 6, 2020 ALIE
NOTICE OF REVIVAL - E-MAILED
Jun 25, 2020 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 24, 2020 TROA
PETITION TO REVIVE-GRANTED
Jun 24, 2020 PETG
TEAS PETITION TO REVIVE RECEIVED
Jun 24, 2020 PROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 21, 2019 GNRN
NON-FINAL ACTION E-MAILED
Dec 21, 2019 GNRT
NON-FINAL ACTION WRITTEN
Dec 21, 2019 CNRT
ASSIGNED TO EXAMINER
Dec 13, 2019 DOCK
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 27, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 27, 2019 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 15, 2019 NWOS
NEW APPLICATION ENTERED
Oct 12, 2019 NWAP